Bank Of America Corp Amryt Pharma PLC Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.0 - $14.77 $2.07 Million - $4.38 Million	296,288 Added 428.81%	365,383 $5.33 Million
Q4 2022 Feb 10, 2023	BUY	$6.68 - $7.58 $7,281 - $8,262	1,090 Added 1.6%	69,095 $504,000
Q3 2022 Nov 14, 2022	BUY	$6.8 - $8.01 $1,700 - $2,002	250 Added 0.37%	68,005 $471,000
Q2 2022 Aug 12, 2022	SELL	$6.85 - $8.87 $7,014 - $9,082	-1,024 Reduced 1.49%	67,755 $473,000
Q1 2022 May 16, 2022	BUY	$6.3 - $10.86 $236,514 - $407,706	37,542 Added 120.18%	68,779 $569,000
Q4 2021 Feb 08, 2022	BUY	$9.44 - $12.24 $124,202 - $161,041	13,157 Added 72.77%	31,237 $337,000
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $172,819 - $223,786	17,946 Added 13392.54%	18,080 $218,000
Q2 2021 Sep 13, 2021	BUY	$10.9 - $14.29 $1,460 - $1,914	134 New	134 $2,000

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.